成人囊性纤维化合并慢性Achromobacter肺部感染的噬菌体治疗研究
该数据集来自 clinicaltrials.gov,聚焦成人囊性纤维化合并慢性 Achromobacter 肺部感染。研究药物 AchromoPhage 是由四种遗传上不同的专性裂解噬菌体(phiACH01、phiACH04、phiACH06、phiACH07)组成的天然噬菌体鸡尾酒,在体外对 17

基本信息
资源简介
成人囊性纤维化合并慢性Achromobacter肺部感染的噬菌体治疗研究
该数据集来自 clinicaltrials.gov,聚焦成人囊性纤维化合并慢性 Achromobacter 肺部感染。研究药物 AchromoPhage 是由四种遗传上不同的专性裂解噬菌体(phiACH01、phiACH04、phiACH06、phiACH07)组成的天然噬菌体鸡尾酒,在体外对 17 株遗传多样性 Achromobacter 分离株中超过 75% 显示活性。本研究为开放标签、随机、Phase 1 试点与可行性试验,在匹兹堡大学开展,评估经吸入、静脉或序贯吸入给药的安全性与耐受性。数据可用于噬菌体治疗、囊性纤维化感染管理等方向(来源 clinicaltrials.gov)。
【数据内容】
源站描述(机器翻译,仅供参考):条件:囊性纤维化(CF)、Achromobacter 感染。AchromoPhage 是一种天然来源的噬菌体鸡尾酒,由四种遗传上不同的专性裂解噬菌体(phiACH01、phiACH04、phiACH06 和 phiACH07)组成,在体外对 Achromobacter 物种具有已证实的活性。该鸡尾酒对从成人囊性纤维化患者中收集的 17 株遗传多样性 Achromobacter 分离株组成的 panel 中超过 75% 显示出活性。本研究旨在评估 AchromoPhage 在患有慢性 Achromobacter 肺部感染的成人囊性纤维化患者中的安全性和耐受性。这是一项在匹兹堡大学开展的开放标签、随机 Phase 1 试点和可行性试验。符合条件的参与者将被随机分配接受 AchromoPhage,通过三种给药途径之一:吸入给药、静脉给药,或序贯吸入后
【主题与分类】
主题标签:Cystic Fibrosis (CF)、Achromobacter Infection。本站分类:呼吸系统疾病。
【获取与许可】
源站页面:https://clinicaltrials.gov/study/NCT07275905
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取
源站:https://clinicaltrials.gov/study/NCT07275905
标准获取流程:
- 访问源站链接,注册/登录账号;
- 进入数据集详情页,按页面指引申请权限或直接下载;
- 部分平台提供 SDK,例如:
- OpenDataLab:
pip install openxlab后openxlab.dataset.get(...) - ModelScope:
pip install modelscope后modelscope download - 天池: 登录后页面提供直链下载
以源站「数据下载/使用文档」页面为准。
- OpenDataLab:
数据说明
Conditions: Cystic Fibrosis (CF), Achromobacter Infection. AchromoPhage is a naturally derived bacteriophage cocktail composed of four genetically distinct, obligately lytic phages (phiACH01, phiACH04, phiACH06, and phiACH07) with demonstrated in vitro activity against Achromobacter species. The cocktail showed activity against more than 75% of a panel of 17 genetically diverse Achromobacter isolates collected from adults with cystic fibrosis. This study is designed to evaluate the safety and tolerability of AchromoPhage in adults with cystic fibrosis who have chronic Achromobacter lung infection. This is an open-label, randomized Phase 1 pilot and feasibility trial conducted at the University of Pittsburgh… Eligible participants will be randomized to receive AchromoPhage by one of three delivery routes: inhaled administration, intravenous administration, or sequential inhaled followed by intravenous administration in the same visit. Each participant will receive three weekly administrations with escalating doses. In addition to evaluating safety and tolerability, the trial will assess lung function and health-related quality of life, characterize pharmacokinetic profiles of AchromoPhage in blood and airway samples, and evaluate the humoral immune response to the administered phages. Exploratory analyses will examine pharmacodynamic effects, including changes in Achromobacter abundance, bacterial community profiles, antibiotic-phage interactions, and phage-pathogen dynamics.
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
需要用于商业化训练或医疗器械注册(NMPA/FDA)?
公开数据往往缺乏完整的病理回证与专家标注。千方医数集依托陕川双基地与超十家三甲医院直连,提供完全合规、去标识化、支持注册级质控的专病数据集交易服务。




